Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study

The transmembrane serine protease 2 (TMPRSS2) is the major host protease that enables entry of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) into host cells by spike (S) protein priming. Single nucleotide polymorphisms (SNPs) in the gene TMPRSS2 have been associated with susceptibility to and severity of H1N1 or H1N9 influenza A virus infections. Functional variants may influence SARS-CoV-2 infection risk and severity of Coronavirus disease 2019 (COVID-19) as well. Therefore, we analyzed the role of SNPs in the gene TMPRSS2 in a German case-control study. We performed genotyping of the SNPs rs2070788, rs383510, and rs12329760 in the gene TMPRSS2 in 239 SARS-CoV-2-positive and 253 SARS-CoV-2-negative patients. We analyzed the association of the SNPs with susceptibility to SARS-CoV-2 infection and severity of COVID-19. SARS-CoV-2-positive and SARS-CoV-2-negative patients did not differ regarding their demographics. The CC genotype of TMPRSS2 rs383510 was associated with a 1.73-fold increased SARS-CoV-2 infection risk, but was not correlated to severity of COVID-19. Neither TMPRSS2 rs2070788 nor rs12329760 polymorphisms were related to SARS-CoV-2 infection risk or severity of COVID-19. In a multivariable analysis (MVA), the rs383510 CC genotype remained an independent predictor for a 2-fold increased SARS-CoV-2 infection risk. In summary, our report appears to be the first showing that the intron variant rs383510 in the gene TMPRSS2 is associated with an increased risk to SARS-CoV-2 infection in a German cohort.

[1]  E. Khusnutdinova,et al.  Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy , 2020, Genes.

[2]  R. Choudhari,et al.  ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease , 2020, Microbial Pathogenesis.

[3]  I. Ariel,et al.  The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences , 2020, Frontiers in Medicine.

[4]  H. Yassine,et al.  Host Genetic Variants Potentially Associated With SARS-CoV-2: A Multi-Population Analysis , 2020, Frontiers in Genetics.

[5]  Jacques Fellay,et al.  Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.

[6]  M. Helmer-Citterich,et al.  COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells , 2020, Genes.

[7]  J. Ramírez-Bello,et al.  Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies , 2020, Life Sciences.

[8]  A. Iolascon,et al.  Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations , 2020, Frontiers in Genetics.

[9]  M. Chung,et al.  New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis , 2020, BMC Medicine.

[10]  Kazuma Uesaka,et al.  Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2 , 2020, Journal of Clinical Pathology.

[11]  J. Erdmann,et al.  Genomewide Association Study of Severe Covid-19 with Respiratory Failure , 2020, The New England journal of medicine.

[12]  Lalu Muhammad Irham,et al.  Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents , 2020, Biochemical and Biophysical Research Communications.

[13]  Paweł P. Łabaj,et al.  Effects of host genetic variations on response to, susceptibility and severity of respiratory infections , 2020, Biomedicine & Pharmacotherapy.

[14]  H. Akhavan-Niaki,et al.  First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations , 2020, Journal of biomolecular structure & dynamics.

[15]  Ashutosh Kumar Singh,et al.  Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human , 2020, Journal of Genetics.

[16]  Roland Eils,et al.  SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells , 2020, The EMBO journal.

[17]  A. Mantovani,et al.  ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy , 2020, medRxiv.

[18]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[19]  Paul Flicek,et al.  The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data , 2016, Nucleic Acids Res..

[20]  M. Obeidat,et al.  Identification of TMPRSS2 as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1) Influenza and A(H7N9) Influenza , 2015, The Journal of infectious diseases.

[21]  K. Shirato,et al.  Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2 , 2013, Journal of Virology.

[22]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[23]  M. Habjan,et al.  TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium , 2013, Journal of Virology.

[24]  Jincun Zhao,et al.  A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry , 2010, Journal of Virology.

[25]  M. Gleave,et al.  Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer , 2008, BMC Cancer.

[26]  M. Peitsch,et al.  Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. , 1997, Genomics.

[27]  J. Luban SARS-CoV-2 , 2020 .